Immediate Impact
5 from Science/Nature 55 standout
Citing Papers
PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
2024 Standout
Chemistries of bifunctional PROTAC degraders
2022 Standout
Works of M. Stoltz being referenced
Phase I Study of the Cyclin-Dependent Kinase Inhibitor Flavopiridol in Combination With Paclitaxel in Patients With Advanced Solid Tumors
2002
Phase II Study of the Cyclin-Dependent Kinase Inhibitor Flavopiridol Administered to Patients With Advanced Gastric Carcinoma
2001
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| M. Stoltz | 229 | 133 | 43 | 226 | 19 | 607 | |
| Kathleen A. Hopp | 83 | 138 | 41 | 275 | 18 | 670 | |
| D Lauri | 131 | 45 | 54 | 297 | 25 | 725 | |
| Ann Van Campenhout | 116 | 47 | 99 | 278 | 14 | 660 | |
| Nelson E. Bruno | 83 | 80 | 29 | 199 | 18 | 549 | |
| Shujuan Huang | 111 | 58 | 39 | 306 | 34 | 659 | |
| Vijay U. Rao | 125 | 53 | 62 | 307 | 19 | 697 | |
| Aejaz Sayeed | 186 | 100 | 11 | 407 | 19 | 669 | |
| H Hojo | 88 | 70 | 94 | 168 | 29 | 576 | |
| J.D. Eneman | 208 | 59 | 32 | 256 | 12 | 725 | |
| Yi-Zhe Wang | 204 | 73 | 25 | 351 | 18 | 598 |
All Works
Login with ORCID to disown or claim papers
Loading papers...